{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:11:00Z","timestamp":1789002660320,"version":"build-2803163510"},"reference-count":108,"publisher":"Ubiquity Press, Ltd.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,2]]},"DOI":"10.5334\/tohm.739","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T06:49:52Z","timestamp":1677739792000},"source":"Crossref","is-referenced-by-count":11,"title":["A Narrative Review of the Lesser Known Medications for Treatment of Restless Legs Syndrome and Pathogenetic Implications for Their Use"],"prefix":"10.5334","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3865-3010","authenticated-orcid":false,"given":"Paul G.","family":"Yeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2914-9074","authenticated-orcid":false,"given":"Karen","family":"Spruyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3349-8426","authenticated-orcid":false,"given":"Lourdes M.","family":"DelRosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5143-7817","authenticated-orcid":false,"given":"Arthur S.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","reference":[{"issue":"4","key":"key20230308074624_B1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s11325-011-0606-x","article-title":"Restless Legs Syndrome: A Comprehensive Overview on Its Epidemiology, Risk Factors, and Treatment","volume":"16","year":"2012","journal-title":"Sleep Breath"},{"issue":"9","key":"key20230308074624_B2","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jmpt.2020.05.004","article-title":"Current Evidence on Diagnostic Criteria, Relevant Outcome Measures, and Efficacy of Nonpharmacologic Therapy in the Management of Restless Legs Syndrome (Rls): A Scoping Review","volume":"43","year":"2020","journal-title":"J Manipulative Physiol Ther"},{"issue":"9","key":"key20230308074624_B3","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.clinph.2004.03.032","article-title":"The Clinical Neurophysiology of the Restless Legs Syndrome and Periodic Limb Movements. Part I: Diagnosis, Assessment, and Characterization","volume":"115","year":"2004","journal-title":"Clin Neurophysiol"},{"issue":"16","key":"key20230308074624_B4","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/mds.22254","article-title":"Treatment of Restless Legs Syndrome: An Evidence-Based Review and Implications for Clinical Practice","volume":"23","year":"2008","journal-title":"Mov Disord"},{"issue":"10","key":"key20230308074624_B5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/mds.22955","article-title":"The Pharmacological Treatment for Uremic Restless Legs Syndrome: Evidence-Based Review","volume":"25","year":"2010","journal-title":"Mov Disord"},{"issue":"8","key":"key20230308074624_B6","first-page":"1039","article-title":"The Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder in Adults--an Update for 2012: Practice Parameters with an Evidence-Based Systematic Review and Meta-Analyses: An American Academy of Sleep Medicine Clinical Practice Guideline","volume":"35","author":"American Academy of Sleep M","year":"2012","journal-title":"Sleep"},{"issue":"7","key":"key20230308074624_B7","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.mayocp.2020.12.026","article-title":"The Management of Restless Legs Syndrome: An Updated Algorithm","volume":"96","author":"Scientific, Medical Advisory Board of the Restless Legs Syndrome F","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"key20230308074624_B8","unstructured":"Picchietti DL. \u201cRestless Legs Syndrome and Periodic Limb Movement Disorder in Children.\u201d Wolters Kluwer, https:\/\/www.uptodate.com\/contents\/restless-legs-syndrome-and-periodic-limb-movement-disorder-in-children\/print?search=Restless%20Legs%20and%20Periodic%20Limb%20Movements%20in%20Children&source=search_result&selectedTitle=1~121&usage_type=default&display_rank=1 (accessed 2022.10.30)."},{"issue":"17","key":"key20230308074624_B9","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1080\/09638288.2018.1453875","article-title":"Non-Pharmacological Interventions for Restless Legs Syndrome: A Systematic Review of Randomised Controlled Trials","volume":"41","year":"2019","journal-title":"Disabil Rehabil"},{"key":"key20230308074624_B10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.sleep.2015.09.009","article-title":"Alternative Treatment of Restless Legs Syndrome: An Overview of the Evidence for Mind-Body Interventions, Lifestyle Interventions, and Neutraceuticals","volume":"17","year":"2016","journal-title":"Sleep Medicine"},{"issue":"2","key":"key20230308074624_B11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1389-9457(03)00010-8","article-title":"Restless Legs Syndrome: Diagnostic Criteria, Special Considerations, and Epidemiology: A Report from the Restless Legs Syndrome Diagnosis and Epidemiology Workshop at the National Institutes of Health","volume":"4","year":"2003","journal-title":"Sleep Medicine"},{"key":"key20230308074624_B12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.smrv.2017.06.003","article-title":"Complementary and Alternative Therapies for Restless Legs Syndrome: An Evidence-Based Systematic Review","volume":"38","year":"2018","journal-title":"Sleep Medicine Reviews"},{"issue":"5","key":"key20230308074624_B13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s40263-015-0250-2","article-title":"Long-Term Treatment of Restless Legs Syndrome (Rls): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation","volume":"29","year":"2015","journal-title":"CNS Drugs"},{"issue":"3","key":"key20230308074624_B14","first-page":"422","article-title":"Restless Legs Syndrome","volume":"10","year":"2004","journal-title":"Journal of alternative and complementary medicine (New York, N.Y.)"},{"issue":"6","key":"key20230308074624_B15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.smrv.2012.01.003","article-title":"Traditional Chinese Medicine Herbal Preparations in Restless Legs Syndrome (Rls) Treatment: A Review and Probable First Description of Rls in 1529","volume":"16","year":"2012","journal-title":"Sleep Medicine Reviews"},{"key":"key20230308074624_B16","first-page":"1789","article-title":"Medical Devices for Restless Legs Syndrome - Clinical Utility of the Relaxis Pad","volume":"11","year":"2015","journal-title":"Ther Clin Risk Manag"},{"issue":"2","key":"key20230308074624_B17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1389-9457(02)00258-7","article-title":"Validation of the International Restless Legs Syndrome Study Group Rating Scale for Restless Legs Syndrome","volume":"4","year":"2003","journal-title":"Sleep Med"},{"issue":"1","key":"key20230308074624_B18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1532-5415.1971.tb01557.x","article-title":"Orphenadrine Citrate (Norflex) for the Treatment of \u201cRestless Legs\u201d and Related Syndromes","volume":"19","year":"1971","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"key20230308074624_B19","first-page":"184","article-title":"Successful Clonidine Treatment of Restless Leg Syndrome in Chronic Kidney Insufficiency","volume":"119","year":"1989","journal-title":"Schweiz Med Wochenschr"},{"issue":"3","key":"key20230308074624_B20","first-page":"132","article-title":"Topiramate Use as Treatment in Restless Legs Syndrome","volume":"32","year":"2004","journal-title":"Actas Esp Psiquiatr"},{"issue":"19","key":"key20230308074624_B21","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM198511073131914","article-title":"Clonidine in the Treatment of \u201cRestless Leg\u201d Syndrome","volume":"313","year":"1985","journal-title":"N Engl J Med"},{"issue":"1","key":"key20230308074624_B22","first-page":"93","article-title":"Preliminary Results with Clonidine in the Restless Legs Syndrome in 2 Hemodialyzed Uremic Patients","volume":"39","year":"1987","journal-title":"Minerva urologica e nefrologica = The Italian journal of urology and nephrology"},{"issue":"4","key":"key20230308074624_B23","first-page":"326","article-title":"Effectiveness of Clonidine in Alleviating the Symptoms of \u201cRestless Legs\u201d","volume":"10","year":"1987","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"key20230308074624_B24","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/sleep\/10.4.398","article-title":"Failure of Clonidine to Ameliorate the Symptoms of Restless Legs Syndrome","volume":"10","year":"1987","journal-title":"Sleep"},{"issue":"1","key":"key20230308074624_B25","first-page":"52","article-title":"Randomized, Double-Blind, Placebo-Controlled Study of Clonidine in Restless Legs Syndrome","volume":"19","year":"1996","journal-title":"Sleep"},{"issue":"7\u20138","key":"key20230308074624_B26","first-page":"878","article-title":"High-Dose Clonidine in a Case of Restless Legs Syndrome","volume":"28","year":"1994","journal-title":"Ann Pharmacother"},{"key":"key20230308074624_B27","doi-asserted-by":"crossref","first-page":"107940","DOI":"10.1016\/j.pharmthera.2021.107940","article-title":"Evidence-Based Pharmacological Treatment Options for Adhd in Children and Adolescents","volume":"230","year":"2022","journal-title":"Pharmacol Ther"},{"key":"key20230308074624_B28","first-page":"320","article-title":"How Do Antihypertensive Drugs Work? Insights from Studies of the Renal Regulation of Arterial Blood Pressure","volume":"7","year":"2016","journal-title":"Front Physiol"},{"key":"key20230308074624_B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sleep.2016.01.017","article-title":"Guidelines for the First-Line Treatment of Restless Legs Syndrome\/Willis-Ekbom Disease, Prevention and Treatment of Dopaminergic Augmentation: A Combined Task Force of the Irlssg, Eurlssg, and the Rls-Foundation","volume":"21","year":"2016","journal-title":"Sleep Med"},{"key":"key20230308074624_B30","unstructured":"Lexicomp. \u201cClonidine: Drug Information\u201d https:\/\/www.uptodate.com\/contents\/clonidine-drug-information?search=clonidine%20drug%20information&source=panel_search_result&selectedTitle=1~148&usage_type=panel&kp_tab=drug_general&display_rank=1 (accessed 2022.10.31)."},{"key":"key20230308074624_B31","first-page":"722","article-title":"Pivotal Role of Adenosine Neurotransmission in Restless Legs Syndrome","volume":"11","year":"2017","journal-title":"Front Neurosci"},{"key":"key20230308074624_B32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/bs.apha.2018.12.005","article-title":"Adenosine Mechanisms and Hypersensitive Corticostriatal Terminals in Restless Legs Syndrome. Rationale for the Use of Inhibitors of Adenosine Transport","volume":"84","year":"2019","journal-title":"Adv Pharmacol"},{"key":"key20230308074624_B33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.sleep.2018.02.002","article-title":"Treatment of Restless Legs Syndrome\/Willis-Ekbom Disease with the Non-Selective Ent1\/Ent2 Inhibitor Dipyridamole: Testing the Adenosine Hypothesis","volume":"45","year":"2018","journal-title":"Sleep Med"},{"issue":"10","key":"key20230308074624_B34","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/mds.28668","article-title":"A Randomized, Placebo-Controlled Crossover Study with Dipyridamole for Restless Legs Syndrome","volume":"36","year":"2021","journal-title":"Mov Disord"},{"key":"key20230308074624_B35","unstructured":"Lexicomp. \u201cDipyridamole: Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/dipyridamole-drug-information?search=dipyridamole&source=panel_search_result&selectedTitle=1~104&usage_type=panel&kp_tab=drug_general&display_rank=1 (accessed 2022.11.02)."},{"issue":"1","key":"key20230308074624_B36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12883-021-02341-2","article-title":"Antiplatelet Drugs for Secondary Prevention in Patients with Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Network Meta-Analysis","volume":"21","year":"2021","journal-title":"BMC Neurol"},{"issue":"22","key":"key20230308074624_B37","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1212\/WNL.0b013e318294b3f6","article-title":"Thalamic Glutamate\/Glutamine in Restless Legs Syndrome: Increased and Related to Disturbed Sleep","volume":"80","year":"2013","journal-title":"Neurology"},{"key":"key20230308074624_B38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.sleep.2017.03.012","article-title":"Treatment of Restless Legs Syndrome with the Selective Ampa Receptor Antagonist Perampanel","volume":"34","year":"2017","journal-title":"Sleep Med"},{"key":"key20230308074624_B39","unstructured":"Lexicomp. \u201cPerampanel: Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/perampanel-drug-information?search=perampanel&source=panel_search_result&selectedTitle=1~15&usage_type=panel&kp_tab=drug_general&display_rank=1 (accessed 2022.10.31)."},{"issue":"2","key":"key20230308074624_B40","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/1531-8257(200003)15:2<324::AID-MDS1020>3.0.CO;2-4","article-title":"Amantadine Is Beneficial in Restless Legs Syndrome","volume":"15","year":"2000","journal-title":"Mov Disord"},{"key":"key20230308074624_B41","unstructured":"Lexicomp. \u201cAmantadine: Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/amantadine-drug-information?search=amantadine&source=panel_search_result&selectedTitle=1~69&usage_type=panel&kp_tab=drug_general&display_rank=1 (accessed 2022.10.31)."},{"issue":"6","key":"key20230308074624_B42","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1213\/00000539-200206000-00034","article-title":"Oral Ketamine: A Promising Treatment for Restless Legs Syndrome","volume":"94","year":"2002","journal-title":"Anesth Analg"},{"key":"key20230308074624_B43","unstructured":"Lexicomp. \u201cKetamine: Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/ketamine-drug-information?search=ketamine&source=panel_search_result&selectedTitle=1~148&usage_type=panel&kp_tab=drug_general&display_rank=1 (accessed 2023.01.29)."},{"issue":"3","key":"key20230308074624_B44","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF01037942","article-title":"Carbamazepine in Restless Legs. A Controlled Pilot Study","volume":"25","year":"1983","journal-title":"Eur J Clin Pharmacol"},{"issue":"6415","key":"key20230308074624_B45","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/bmj.288.6415.444","article-title":"Treatment of the Restless Legs Syndrome with Carbamazepine: A Double Blind Study","volume":"288","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"3","key":"key20230308074624_B46","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.genhosppsych.2006.02.009","article-title":"Oxcarbazepine Treatment for Paroxetine-Induced Restless Leg Syndrome","volume":"28","year":"2006","journal-title":"Gen Hosp Psychiatry"},{"issue":"3","key":"key20230308074624_B47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/WNF.0b013e31818f1125","article-title":"Oxcarbazepine Treatment of Restless Legs Syndrome: Three Case Reports","volume":"32","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"key20230308074624_B48","unstructured":"Lexicomp. \u201cCarbamazepine: Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/carbamazepine-drug-information?search=carbamazepine&source=panel_search_result&selectedTitle=1~148&usage_type=panel&kp_tab=drug_general&display_rank=1 (accessed 2022.10.31)."},{"key":"key20230308074624_B49","unstructured":"Lexicomp. \u201cOxcarbazepine: Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/oxcarbazepine-drug-information?search=oxcarbazepine&source=panel_search_result&selectedTitle=1~121&usage_type=panel&kp_tab=drug_general&display_rank=1 (accessed 2022.10.31)."},{"issue":"1","key":"key20230308074624_B50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.sleep.2004.10.009","article-title":"Pilot Trial of Lamotrigine in the Restless Legs Syndrome","volume":"6","year":"2005","journal-title":"Sleep Med"},{"issue":"3","key":"key20230308074624_B51","first-page":"69","article-title":"Treatment of Bipolar Disorder, Restless Legs Syndrome and Parkinsonian Symptoms Using Lamotrigine: A Report of Seven Patients","volume":"103","year":"2007","journal-title":"J S C Med Assoc"},{"key":"key20230308074624_B52","unstructured":"Lexicomp. \u201cLamotrigine: Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/lamotrigine-drug-information?search=lamotrigine&source=panel_search_result&selectedTitle=1~135&usage_type=panel&kp_tab=drug_general&display_rank=1 (accessed 2022.11.05)."},{"issue":"8","key":"key20230308074624_B53","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s00415-007-0243-z","article-title":"Topiramate-Induced Restless Legs Syndrome: A Report of Two Cases","volume":"254","year":"2007","journal-title":"J Neurol"},{"issue":"4","key":"key20230308074624_B54","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s00415-009-0073-5","article-title":"Restless Legs Syndrome Induced by Topiramate: Two More Cases","volume":"256","year":"2009","journal-title":"J Neurol"},{"key":"key20230308074624_B55","unstructured":"Lexicomp. \u201cTopiramate: Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/topiramate-drug-information?search=topiramate&source=panel_search_result&selectedTitle=1~148&usage_type=panel&kp_tab=drug_general&display_rank=1 (accessed 2022.11.01)."},{"issue":"5","key":"key20230308074624_B56","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/00004714-200010000-00013","article-title":"Valproate for Sleep Consolidation in Periodic Limb Movement Disorder","volume":"20","year":"2000","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"key20230308074624_B57","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00415-004-0367-6","article-title":"Treatment of Idiopathic Restless Legs Syndrome (Rls) with Slow-Release Valproic Acid Compared with Slow-Release Levodopa\/Benserazid","volume":"251","year":"2004","journal-title":"J Neurol"},{"key":"key20230308074624_B58","unstructured":"Lexicomp. \u201cValproate: Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/valproate-drug-information?search=valproic%20acid&source=panel_search_result&selectedTitle=1~148&usage_type=panel&kp_tab=drug_general&display_rank=1 (accessed 2022.10.31)."},{"issue":"4","key":"key20230308074624_B59","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1136\/jnnp.2005.075671","article-title":"Levetiracetam Can Be Effective in the Treatment of Restless Legs Syndrome with Periodic Limb Movements in Sleep: Report of Two Cases","volume":"77","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"key20230308074624_B60","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.braindev.2010.09.008","article-title":"Restless Leg Syndrome in Adhd Children: Levetiracetam as a Reasonable Therapeutic Option","volume":"33","year":"2011","journal-title":"Brain Dev"},{"key":"key20230308074624_B61","unstructured":"Lexicomp. \u201cLevetiracetam: Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/levetiracetam-drug-information?search=levetiracetam&source=panel_search_result&selectedTitle=1~108&usage_type=panel&kp_tab=drug_general&display_rank=1 (accessed 2022.11.03)."},{"issue":"4","key":"key20230308074624_B62","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.smrv.2011.09.003","article-title":"Restless Legs Syndrome--Theoretical Roles of Inflammatory and Immune Mechanisms","volume":"16","year":"2012","journal-title":"Sleep Med Rev"},{"issue":"18","key":"key20230308074624_B63","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1212\/01.wnl.0000310984.45538.89","article-title":"Low-Dose Hydrocortisone in the Evening Modulates Symptom Severity in Restless Legs Syndrome","volume":"70","year":"2008","journal-title":"Neurology"},{"issue":"6","key":"key20230308074624_B64","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.sleep.2009.11.010","article-title":"Oral Glucocorticosteroids: Effective in a Case of Restless Legs Syndrome Resistant to Other Therapies","volume":"11","year":"2010","journal-title":"Sleep Med"},{"key":"key20230308074624_B65","unstructured":"Lexicomp. \u201cPrednisolone (Systemic): Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/prednisolone-systemic-drug-information?search=glucocorticoids&selectedTitle=1~146&usage_type=panel&display_rank=1&kp_tab=drug_general&source=panel_search_result (accessed 2022.10.31)."},{"key":"key20230308074624_B66","unstructured":"Lexicomp. \u201cHydrocortisone (Systemic): Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/hydrocortisone-systemic-drug-information?search=hydrocortisone&source=panel_search_result&selectedTitle=1~145&usage_type=panel&showDrugLabel=true&display_rank=1 (accessed 2022.11.07)."},{"key":"key20230308074624_B67","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.sleep.2017.04.019","article-title":"Cannabis for Restless Legs Syndrome: A Report of Six Patients","volume":"36","year":"2017","journal-title":"Sleep Med"},{"key":"key20230308074624_B68","doi-asserted-by":"crossref","first-page":"2054358120954944","DOI":"10.1177\/2054358120954944","article-title":"Cannabis Use for Restless Legs Syndrome and Uremic Pruritus in in Patients Treated with Maintenance Dialysis: A Survey","volume":"7","year":"2020","journal-title":"Can J Kidney Health Dis"},{"key":"key20230308074624_B69","unstructured":"Lexicomp. \u201cCannabidiol: Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/cannabidiol-drug-information?search=cannabidiol&source=panel_search_result&selectedTitle=1~53&usage_type=panel&kp_tab=drug_general&display_rank=1 (accessed 2023.01.28)."},{"key":"key20230308074624_B70","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.smrv.2017.06.002","article-title":"The Influence of Antidepressants on Restless Legs Syndrome and Periodic Limb Movements: A Systematic Review","volume":"38","year":"2018","journal-title":"Sleep Med Rev"},{"issue":"4","key":"key20230308074624_B71","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4306\/pi.2009.6.4.313","article-title":"Resolution of Pregabalin and Mirtazapine Associated Restless Legs Syndrome by Bupropion in a Patient with Major Depressive Disorder","volume":"6","year":"2009","journal-title":"Psychiatry Investig"},{"issue":"2","key":"key20230308074624_B72","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1345\/aph.1L035","article-title":"Bupropion as a Possible Treatment Option for Restless Legs Syndrome","volume":"43","year":"2009","journal-title":"Ann Pharmacother"},{"issue":"6","key":"key20230308074624_B73","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.wnf.0000194706.61224.29","article-title":"Bupropion May Improve Restless Legs Syndrome: A Report of Three Cases","volume":"28","year":"2005","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"key20230308074624_B74","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3122\/jabfm.2011.04.100173","article-title":"Bupropion and Restless Legs Syndrome: A Randomized Controlled Trial","volume":"24","year":"2011","journal-title":"J Am Board Fam Med"},{"issue":"4","key":"key20230308074624_B75","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4103\/0972-2327.194424","article-title":"A Double-Blind, Randomized, Controlled Trial to Compare the Efficacy and Tolerability of Fixed Doses of Ropinirole, Bupropion, and Iron in Treatment of Restless Legs Syndrome (Willis-Ekbom Disease)","volume":"19","year":"2016","journal-title":"Ann Indian Acad Neurol"},{"key":"key20230308074624_B76","unstructured":"Lexicomp. \u201cBupropion: Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/bupropion-drug-information?search=bupropion&source=panel_search_result&selectedTitle=1~148&usage_type=panel&kp_tab=drug_general&display_rank=1 (accessed 2022.10.31)."},{"issue":"3","key":"key20230308074624_B77","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ana.410150304","article-title":"Effect of Baclofen on Sleep-Related Periodic Leg Movements","volume":"15","year":"1984","journal-title":"Ann Neurol"},{"issue":"6","key":"key20230308074624_B78","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00004714-198812000-00017","article-title":"The Effects of Baclofen in the Restless Legs Syndrome: Evidence for Endogenous Opioid Involvement","volume":"8","year":"1988","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"key20230308074624_B79","first-page":"591","article-title":"Transverse Myelitis Associated with Restless Legs Syndrome and Periodic Movements of Sleep Responsive to an Oral Dopaminergic Agent but Not to Intrathecal Baclofen","volume":"23","year":"2000","journal-title":"Sleep"},{"key":"key20230308074624_B80","unstructured":"Lexicomp. \u201cBaclofen: Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/baclofen-drug-information?search=baclofen&source=panel_search_result&selectedTitle=1~96&usage_type=panel&kp_tab=drug_general&display_rank=1 (accessed 2022.10.31)."},{"issue":"3","key":"key20230308074624_B81","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1213\/01.ANE.0000159376.47974.71","article-title":"Physostigmine for the Acute Treatment of Restless Legs Syndrome","volume":"101","year":"2005","journal-title":"Anesth Analg"},{"issue":"5","key":"key20230308074624_B82","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/ALN.0b013e31826e7038","article-title":"Physostigmine and Restless Legs Syndrome","volume":"117","year":"2012","journal-title":"Anesthesiology"},{"key":"key20230308074624_B83","unstructured":"Lexicomp. \u201cPhysostigmine: Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/physostigmine-drug-information?search=physostigmine&source=panel_search_result&selectedTitle=1~25&usage_type=panel&kp_tab=drug_general&display_rank=1 (accessed 2023.01.29)."},{"key":"key20230308074624_B84","unstructured":"Lexicomp. \u201cOrphenadrine: Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/orphenadrine-drug-information?search=orphenadrine&source=panel_search_result&selectedTitle=1~9&usage_type=panel&kp_tab=drug_general&display_rank=1 (accessed 2022.11.01)."},{"issue":"6","key":"key20230308074624_B85","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.sleep.2011.03.007","article-title":"Restless Legs Syndrome Is Associated with Irritable Bowel Syndrome and Small Intestinal Bacterial Overgrowth","volume":"12","year":"2011","journal-title":"Sleep Med"},{"issue":"5","key":"key20230308074624_B86","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1007\/s10620-007-0021-0","article-title":"Restless Legs Syndrome in Patients with Irritable Bowel Syndrome: Response to Small Intestinal Bacterial Overgrowth Therapy","volume":"53","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"4","key":"key20230308074624_B87","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.sleep.2009.06.005","article-title":"Antibiotic Therapy May Improve Idiopathic Restless Legs Syndrome: Prospective, Open-Label Pilot Study of Rifaximin, a Nonsystemic Antibiotic","volume":"11","year":"2010","journal-title":"Sleep Med"},{"key":"key20230308074624_B88","unstructured":"Lexicomp. \u201cRifaximin: Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/rifaximin-drug-information?search=rifaximin&source=panel_search_result&selectedTitle=1~45&usage_type=panel&kp_tab=drug_general&display_rank=1 (accessed 2022.10.31)."},{"issue":"3","key":"key20230308074624_B89","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5664\/jcsm.26585","article-title":"Successful Treatment of Recalcitrant Restless Legs Syndrome with Botulinum Toxin Type-A","volume":"2","year":"2006","journal-title":"J Clin Sleep Med"},{"issue":"10","key":"key20230308074624_B90","article-title":"Botulinum Toxin in Restless Legs Syndrome-a Randomized Double-Blind Placebo-Controlled Crossover Study","volume":"10","year":"2018","journal-title":"Toxins (Basel)"},{"issue":"11","key":"key20230308074624_B91","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/00207454.2011.602774","article-title":"Pilot Trial of Onabotulinumtoxina (Botox) in Moderate to Severe Restless Legs Syndrome","volume":"121","year":"2011","journal-title":"Int J Neurosci"},{"issue":"10","key":"key20230308074624_B92","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.sleep.2012.08.019","article-title":"A Phase Ii, Open-Label, Non-Comparative Study of Botulinum Toxin in Restless Legs Syndrome","volume":"13","year":"2012","journal-title":"Sleep Med"},{"issue":"12","key":"key20230308074624_B93","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1212\/01.wnl.0000325994.93782.a1","article-title":"Double-Blind, Placebo-Controlled, Pilot Trial of Botulinum Toxin a in Restless Legs Syndrome","volume":"71","year":"2008","journal-title":"Neurology"},{"key":"key20230308074624_B94","unstructured":"Lexicomp. \u201cOnabotulinumtoxina (Botox): Drug Information \u201cOnabotulinumtoxina (Botox): Drug Information - Uptodate\u201d.\u201d https:\/\/www.uptodate.com\/contents\/onabotulinumtoxina-botox-drug-information?source=auto_suggest&selectedTitle=1~1---1~4---botox&search=botox"},{"key":"key20230308074624_B95","unstructured":"Lexicomp. \u201cRimabotulinumtoxinb (Myobloc): Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/rimabotulinumtoxinb-myobloc-drug-information?source=auto_suggest&selectedTitle=1~1---1~4---rimabotulinum&search=rimabotulinumtoxinb (accessed 2023.01.23)."},{"issue":"2","key":"key20230308074624_B96","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/mds.10082","article-title":"Treatment of Periodic Limb Movements in Sleep with Selegiline Hcl","volume":"17","year":"2002","journal-title":"Mov Disord"},{"key":"key20230308074624_B97","unstructured":"Lexicomp. \u201cSelegiline: Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/selegiline-drug-information?source=auto_suggest&selectedTitle=1~1---1~4---selegiline&search=selegiline (accessed 2023.01.29)."},{"issue":"6","key":"key20230308074624_B98","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1212\/WNL.0b013e3181cef824","article-title":"Availability of Brain Serotonin Transporters in Patients with Restless Legs Syndrome","volume":"74","year":"2010","journal-title":"Neurology"},{"key":"key20230308074624_B99","doi-asserted-by":"crossref","unstructured":"Lexicomp. \u201cCyproheptadine: Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/cyproheptadine-drug-information?source=auto_suggest&selectedTitle=1~1---1~4---cyproheptadine&search=cyproheptadine (accessed 2023.01.29). DOI: 10.1093\/sleep\/zsz223","DOI":"10.1093\/sleep\/zsz223"},{"issue":"2","key":"key20230308074624_B100","article-title":"Striatal Histamine Mechanism in the Pathogenesis of Restless Legs Syndrome","volume":"43","year":"2020","journal-title":"Sleep"},{"issue":"1","key":"key20230308074624_B101","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40263-021-00886-x","article-title":"Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials","volume":"36","year":"2022","journal-title":"CNS Drugs"},{"issue":"1","key":"key20230308074624_B102","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.sleep.2007.11.002","article-title":"Circadian Rhythm of Csf Monoamines and Hypocretin-1 in Restless Legs Syndrome and Parkinson\u2019s Disease","volume":"10","year":"2009","journal-title":"Sleep Med"},{"issue":"4","key":"key20230308074624_B103","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1212\/WNL.59.4.639","article-title":"Increased Csf Hypocretin-1 (Orexin-a) in Restless Legs Syndrome","volume":"59","year":"2002","journal-title":"Neurology"},{"issue":"10","key":"key20230308074624_B104","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1212\/01.WNL.0000094196.50155.38","article-title":"Csf Hypocretin-1 Levels in Restless Legs Syndrome","volume":"61","year":"2003","journal-title":"Neurology"},{"key":"key20230308074624_B105","unstructured":"Lexicomp. \u201cPitolisant: Drug Information.\u201d https:\/\/www.uptodate.com\/contents\/pitolisant-drug-information?source=auto_suggest&selectedTitle=1~1---1~4---pitol&search=pitolisant (accessed 2023.01.29)."},{"issue":"10","key":"key20230308074624_B106","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.sleep.2014.05.019","article-title":"Restless Legs Syndrome and Central Nervous System Gamma-Aminobutyric Acid: Preliminary Associations with Periodic Limb Movements in Sleep and Restless Leg Syndrome Symptom Severity","volume":"15","year":"2014","journal-title":"Sleep Med"},{"issue":"4","key":"key20230308074624_B107","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41397-018-0023-7","article-title":"Gamma-Aminobutyric Acid (Gaba) Receptors Genes Polymorphisms and Risk for Restless Legs Syndrome","volume":"18","year":"2018","journal-title":"Pharmacogenomics J"},{"key":"key20230308074624_B108","doi-asserted-by":"crossref","first-page":"107966","DOI":"10.1016\/j.neuropharm.2020.107966","article-title":"Mechanisms of Action of Currently Used Antiseizure Drugs","volume":"168","year":"2020","journal-title":"Neuropharmacology"}],"container-title":["Tremor and Other Hyperkinetic Movements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/storage.googleapis.com\/jnl-up-j-tohm-files\/journals\/1\/articles\/739\/submission\/proof\/739-1-5598-2-10-20230308.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:54:37Z","timestamp":1761551677000},"score":1,"resource":{"primary":{"URL":"https:\/\/tremorjournal.org\/articles\/10.5334\/tohm.739\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3,2]]}},"alternative-id":["10.5334\/tohm.739"],"URL":"https:\/\/doi.org\/10.5334\/tohm.739","relation":{},"ISSN":["2160-8288"],"issn-type":[{"value":"2160-8288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"7"}}